Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew    SN.   GB0009223206

SMITH & NEPHEW (SN.)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/17/2017 10/18/2017 10/19/2017 10/20/2017 10/23/2017 Date
1421(c) 1421(c) 1413(c) 1428(c) 1424 Last
5 380 131 2 837 683 3 433 994 4 764 897 172 399 Volume
+0.14% 0.00% -0.56% +1.06% -0.28% Change
More quotes
Financials ($)
Sales 2017 4 803 M
EBIT 2017 981 M
Net income 2017 658 M
Debt 2017 1 156 M
Yield 2017 1,76%
Sales 2018 5 022 M
EBIT 2018 1 047 M
Net income 2018 710 M
Debt 2018 754 M
Yield 2018 1,87%
P/E ratio 2017 24,34
P/E ratio 2018 22,91
EV / Sales2017 3,67x
EV / Sales2018 3,43x
Capitalization 16 476 M
More Financials
Company
Smith & Nephew Plc is a global orthopedics company.It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management.The company operates in two divisions: Advanced Surgical Devices and Advanced Wound Management.The Advanced... 
More about the company
Surperformance© ratings of Smith & Nephew
Trading Rating : Investor Rating :
More Ratings
Latest news on SMITH & NEPHEW
10/20 SMITH & NEPHEW : Notice of Results - Clarification
10/17 SMITH & NEPHEW : False Advertising by Smith & Nephew Can Put Patients At Risk of..
10/17 SMITH & NEPHEW : 65-- Smith & nephew Endoscope punches
10/17 SMITH & NEPHEW : 65-- Smith & nephew Endoscope punches correction to CLINS
10/17 SMITH & NEPHEW : Timing of Smith & Nephew third quarter trading report
10/13 SMITH & NEPHEW : Notice of Results
10/11 Mondi drags on FTSE, Provident Financial sinks
10/11 SMITH & NEPHEW : Notice of Chief Executive Officer's intention to retire by end ..
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
10/10 SMITH & NEPHEW : chief exec will retire next year
More news
Sector news : Medical Devices & Implants
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/09 LafargeHolcim poaches Essilor's finance chief
10/05DJJOHNSON & JOHNSON : Abandoning Insulin Pumps
More sector news : Medical Devices & Implants
4-Traders Strategies on SMITH & NEPHEW 
SMITH & NEPHEW  - 2015
Near a major level
SELL
SMITH & NEPHEW PLC - 2013
Lower limit of a trading channel
BUY
More Strategies
Latest Tweets
09/12'Tripe is what dogs really love to eat': Butcher’s Pet Care founder Graham Ba..
5
09/12My First Million — pet food entrepreneur Graham Baker
1
07/21Baker Graham Dental hosting grand opening for new location  
03/21Catalent : Biologics Announces Appointment of Matthew Stober to Advisory Boar.. 
2016$SNN: Smith & Nephew names Graham Baker as CFO effective March 1, 2017  
More tweets
Qtime:153
News from SeekingAlpha
10/12 YOUR DAILY PHARMA SCOOP : AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopress..
10/11 Activist Investors Influence Stocks - Cramer's Mad Money (10/10/17)
10/11 Premarket analyst action - healthcare
10/10 Smith & Nephew up more than 8% on report of Elliott stake
10/04 Smith & Nephew goes ex-dividend tomorrow
Chart SMITH & NEPHEW
Duration : Period :
Smith & Nephew Technical Analysis Chart | SN. | GB0009223206 | 4-Traders
Technical analysis trends SMITH & NEPHEW
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 17,8 $
Spread / Average Target -5,4%
EPS Revisions
Managers
NameTitle
Olivier Jean Bohuon Chief Executive Officer & Director
Roberto Quarta Chairman
Matthew R. Stober President-Global Operations
Graham Baker Chief Financial Officer & Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW16.95%16 438
STRYKER CORPORATION25.61%56 293
WRIGHT MEDICAL GROUP NV15.10%2 772
JAPAN LIFELINE CO., LTD.131.13%2 146
GLAUKOS CORP-1.98%1 158
OSSTEM IMPLANT CO LTD--.--%870